Skip Navigation

Phase II Trial of Intravesical Gemcitabine and MK-3475 Pembrolizumab in the Treatment of Patients with BCGUnresponsive Non-Muscle Invasive Bladder Cancer

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04164082

Study #:
STUDY00147180

Start Date:
Jun 30, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04164082

View Complete Trial Details & Eligibility at ClinicalTrials.gov